In Vitro and In Vivo Insights into a Broccoli Byproduct as a Healthy Ingredient for the Management of Alzheimer’s Disease and Aging through Redox Biology

Broccoli has gained popularity as a highly consumed vegetable due to its nutritional and health properties. This study aimed to evaluate the composition profile and the antioxidant capacity of a hydrophilic extract derived from broccoli byproducts, as well as its influence on redox biology, Alzheimer’s disease markers, and aging in the Caenorhabditis elegans model. The presence of glucosinolate was observed and antioxidant capacity was demonstrated both in vitro and in vivo. The in vitro acetylcholinesterase inhibitory capacity was quantified, and the treatment ameliorated the amyloid-β- and tau-induced proteotoxicity in transgenic strains via SOD-3 and SKN-1, respectively, and HSP-16.2 for both parameters. Furthermore, a preliminary study on aging indicated that the extract effectively reduced reactive oxygen species levels in aged worms and extended their lifespan. Utilizing broccoli byproducts for nutraceutical or functional foods could manage vegetable processing waste, enhancing productivity and sustainability while providing significant health benefits.


■ INTRODUCTION
Broccoli (Brassica oleracea var.italica) is a plant belonging to the Brassicaceae family that has gained significant popularity as a highly consumed vegetable, becoming a staple in diets and markets.However, the process of harvesting broccoli generates a substantial number of residues and byproducts, including leaves, stalks, and damaged or low-marketable florets, which seemingly hold little or no economic value. 1 In fact, those materials constitute more than 95% of the harvested material. 2he agri-food industry produces numerous byproducts that can serve as valuable sources of nutrients and potentially functional ingredients, offering opportunities to create valueadded products. 3Broccoli and its byproducts possess a high nutritional value, due to its wealth in dietary fiber, vitamins (A and C), and essential mineral nutrients (calcium and iron) in its composition.Moreover, they contain bioactive compounds such as numerous phenolic compounds (especially flavonoids and hydroxycinnamic acids) and glucosinolates. 1,2Different functions have been attributed to this vegetable and its biological properties may contribute to improve well-being for consumers, like reducing the risk of chronic diseases including neurodegenerative and promoting health status. 2 An important challenge with great scientific interest due to its social, economic, and health relevance is the aging of the population.The projected number of individuals over 80 years or older is anticipated to triple between 2020 and 2050, reaching approximately 426 million. 4Aging is not a disease, but a physiological process that instead is closely related to the so-called age-related diseases, including Alzheimer's disease (AD).AD is the most prevalent neurodegenerative disorder, with cognitive impairment and memory loss as the main symptoms.There are several hypotheses about AD etiology, including the oxidative stress theory, cholinergic hypothesis, amyloid cascade hypothesis, and tau protein hyperphosphorylation hypothesis. 5−8 Furthermore, the senile depositions in the form of Aβ plaques and neurofibrillary tangles of hyperphosphorylated tau protein have been correlated with the elevated levels of reactive oxygen species (ROS) and oxidative stress markers such as lipid peroxidation products, 9,10 and with the decrease in the antioxidant defense 10,11 in AD patients.The cumulative impact of increased oxidative stress due, in turn, to Aβ plaques and hyperphosphorylated tau deposits can lead to cellular deterioration, potentially resulting in cell death or apoptosis. 12,13As the aging population grows, AD incidence does too.The lack of effective treatments makes necessary the exploration of strategies to prevent or slow automatic fragmentation mode, isolating and fragmenting the two most intense mass peaks, with the following collision energy values: 10, 20, and 40 eV.MS/MS data were acquired using the centroid mode at a rate of 2.5 spectra/s in the extended dynamic range mode (2 GHz).All data acquisition operations were controlled with Masshunter workstation software version B.06.00 (Agilent Technologies).The main compounds in the extract were automatically detected using a compound extraction algorithm based on molecular feature detection, and the resulting peaks were filtered with a relative volume threshold of 0.3% as well as those that appeared in the solvent blank.The compounds detected by this algorithm were tentatively identified, whenever possible, with the help of compound databases (SciFinder, HMDB, Metlin, etc.) and scientific literature related to vegetables, based on the molecular formula obtained from the exact mass and isotopic distribution data to the retention times and fragmentation patterns recorded.
In Vitro Assay of the Acetylcholinesterase (AChE) Inhibitory Activity.Ellman's modified method was used. 21AChE activity was determined using 150 μM 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB), 150 μM acetylthiocholine iodide (ATCh) (substrate), and 10 mU/mL AChE (in 50 mM Tris-HCl buffer, pH 8.0).AChE was incubated in 96-plate wells with DTNB and different concentrations of the extract, the inhibition control physostigmine (PHY), or Milli-Q water (positive control of AChE activity) for 15 min at 30 °C.Then, the substrate was added and absorbance changes at 405 nm for 25 min at 30 °C were measured.AChE inhibitory activity was presented as percentage (%) of inhibition compared with the positive control.The concentration of the extract causing 50% inhibition of AChE activity (IC 50 ) was determined by regression analysis.bkIs10 [aex-3p::hTau V337 M + myo-2p::GFP]).All of them were maintained in an incubator (VELP Scientifica FOC 120 E, Usmate, Italy) at 20 °C, except for CL4176 and CL802 that were kept at 16 °C.Worms were cultured on plates with nematode growth media (NGM) spread with Escherichia coli OP50, which was used by the worms as a source of food.Both the worms and bacteria were obtained from the Caenorhabditis Genetics Center (CGC) (Minneapolis, Michigan).Age-synchronized nematodes were used for all of the experiments, unless otherwise specified, obtained from gravid hermaphrodite adults treated with bleaching solution (0.5 N NaOH in 20% bleach).

C. elegans
Lethality Test.The death rate of N2 worms subjected to BRO (0, 100, 500, 1000, 5000, 7500, and 10 000 μg/mL) was used to assess acute toxicity in a concentration−response curve.L3 larvae were exposed to treatment for 24 h at 20 °C without food.Then, survival % was calculated using a microscope (Motic Inc., Ltd., Hong Kong, China).Each independent assay consisted of at least three NGM plates with at least 10 worms each.
Egg Viability Evaluation.Gravid N2 nematodes cultivated in standard conditions were subjected to synchronization, and the obtained eggs were placed in plates containing E. coli OP50 plus the treatments (0, 100, 500, 1000, 5000, 7500, and 10 000 μg/mL).After 24 h, the number of larvae was counted using a microscope.At least 40 eggs per group were used.Data were presented as the percentage of hatched eggs per group.
Lifespan Curves.N2 strain was used to perform survival curves in order to evaluate the potential long-term toxic effect of BRO. 22One hundred and twenty L3 synchronized worms were placed on fresh plates containing the treatments or the control plus E. coli OP50 and maintained at 20 °C.The concentrations used were 100, 500, 1000, 5000, 7500, and 10 000 μg/mL.The compound 5-fluoro-2′deoxyuridine (FUDR) (Sigma-Aldrich, St. Louis, Missouri) was used to prevent egg-laying during the fertile phase.The experiment commences at the L3 because this stage is considered ideal due to the FUDR embryotoxicity and the optimal efficacy of FUDR requires its application prior to the reproductive development of the worms.Worms were then scored for survival every day and transferred to fresh plates twice per week.Death was recorded when no response to a mechanical stimulus was observed.Animals that were removed from the dish or dead from progeny in utero were not included in the death count (censored).For each dosage, Kaplan−Meier curves were presented.
Measurement of Intracellular Reactive Oxygen Species (ROS) Content.N2 synchronized eggs were placed on plates with or without the treatments (0, 100, 500, and 1000 μg/mL) and incubated for 48 h at 20 °C.After that, all groups were washed with M9 medium and exposed (except the CTL basal group) to 2.5 mM 2,2′-azobis-2amidinopropane dihydrochloride (AAPH) for 15 min.Then, the AAPH was removed by wash with M9, and worms were incubated for 2 h with 25 μM dichlorodihydrofluorescein diacetate (DCFDA) at 20 °C.A Multi-Range Large Particle Flow Cytometer Biosorter (Union Biometrica, Massachusetts, USA) was used to measure the fluorescence intensity of, at least, 300 worms per group.ROS content was estimated as a percentage of control of average yellow fluorescence intensity.
Redox Biology-Related Genes Measured in Green Fluorescent Protein (GFP)-Reporter Transgenic Strains.Transgenic LD1 and TJ356 nematodes express the fusion of the genes encoding the transcription factors SKN-1/Nuclear factor erythroid 2-related factor 2 (Nrf2) and DAF-16/Forkhead box transcription factors class O (FOXO), respectively.TJ375 and OS3062 worms express the hsp-16.2and the combination of hsf-1:hsp-16.2:hsp-16.41genes.The sod-3 gene is expressed in the transgenic CF1553, and the gst-4 in the strain CL2166.In all of them, the gene is fused with the GFP.For all strains, synchronized eggs were placed on control plates or plates containing BRO at concentrations of 100, 500, and 1000 μg/mL and maintained for 48 h.Subsequently, nematodes were immobilized on glass slides containing sodium azide to limit their movement.Worm images were captured with the 10× objective for all strains, except for TJ375 and OS3062, which were observed using 40× magnification.A Nikon epifluorescence microscope (Eclipse Ni, Nikon, Tokyo, Japan) equipped with a Nikon DS-Ri2 camera (Tokyo, Japan) and the GFP filter was utilized.NIS-Elements BR software (Nikon, Tokyo, Japan) was used for analysis.For the TJ356 strain, a semiquantitative scale was applied, assigning a value of "1" to worms exhibiting cytosolic expression of DAF-16::GFP, "2" to those with intermediate status, and "3" to worms showing nuclear localization.Then, the results were normalized and expressed as percentage to the control group.The fluorescence intensity of the entire worm was measured for LD1, CF1553, and CL2166.The area anterior of the pharyngeal bulb was measured for HSP16.2::GFP and HSF-1:HSP-16.2:HSP-16.41::GFP in TJ375 and OS3062 worms, respectively.
Paralysis Assay.The paralysis assay was conducted following the methodology already described. 23The CL4176 strain harbors a temperature-sensitive mutation that induces the expression of human Aβ 1−42 peptide in muscle cells, leading to paralysis in the nematode.Synchronized eggs from CL4176 were distributed onto plates containing different concentrations of the extract (0, 100, 500, and 1000 μg/mL) along with E. coli OP50 as a food source.Nonparalyzable strain CL802 was used as a negative control in the experiment.Plates were incubated at 16 °C for 48 h and then shifted to 25 °C to induce Aβ expression.Paralysis was assessed from 20 to 32 h after temperature shifting, with each group and replicate including at least 25 worms.Results are presented as curves depicting the percentage (%) of nonparalyzed worms over time.
Aβ Plaques Staining.Thioflavin T dye was used with the aim of visualizing Aβ aggregates in the CL4176 strain as described. 14Worms and plates were treated as for the paralysis assay and, approximately at the time for 50% of paralysis of the nontreated group, the nematodes were collected by wash with M9.Then, they were fixed by using 4% paraformaldehyde (pH 7.4) at 4 °C for 24 h, followed by the application of permeabilization buffer (5% β-mercaptoethanol, 1% Triton X-100, and 125 mM Tris, pH 7.4).After 24 h at 37 °C, the buffer was removed by washing with M9 and 0.125% thioflavin T was used for the staining of the samples for 30 min.Subsequently, they were distained with sequential ethanol washes (50%, 75%, 90%, 75%, and 50% v/v, each one for 2 min).Thioflavin T-stained worms were

Journal of Agricultural and Food Chemistry
visualized using a Nikon epi-fluorescence microscope (Eclipse Ni, Nikon, Tokyo, Japan) at 40× magnification.Images were captured with a Nikon DS-Ri2 camera (Tokyo, Japan) using the GFP filter.
Tau Proteotoxicity Assessment.BR5706 strain, characterized by pan-neuronal expression of Tau protein aggregates, displayed locomotion defects upon reaching adulthood.After incubating BR5706 worms with 100, 500, and 1000 μg/mL or without treatments for 72 h at 20 °C, animals were induced to swim to assess their movement.WormLab Imaging System (MBF Bioscience, Williston, Vermont, USA) was utilized to record, track, and analyze worm movement, focusing on swimming speed and activity index as representative locomotive behavior parameters.
Silencing of Targeted Genes by RNA Interference (RNAi) Technology.The RNAi technology was employed to inhibit the expression of target genes in both the paralysis test and the tau proteotoxicity evaluation test.E. coli HT115 expressing DAF-16/ FOXO, SOD-3 (Cultek SL, Madrid, Spain), SKN-1/Nrf2, and HSP-16.2(Sources BioScience, Nottingham, UK) dsRNA were spread on NGM plates.Isopropyl β-d-1-thiogalactopyranoside (IPTG) (1 mM) and carbenicillin (25 μg/mL) were added to the medium.L3−L4 synchronized worms (F0) were placed into the RNAi plates and, from them, eggs (F1) were isolated.Those eggs belonging to CL4176 and BR5706 were placed into the plates containing treatments with each RNAi and a plate without the RNAi.From this step, the experiments were carried out as explained above.
Measurement of Intracellular and Mitochondrial ROS Content in Aged Nematodes.The following protocols, represented in a scheme gathered in Figure 1, were applied to young (5 days old) and aged (12 days old) worms in a baseline situation.L3 stagesynchronized N2 nematodes were exposed to 100 μg/mL BRO or the respective control.Worms were incubated at 20 °C until the readout point.After that time, intracellular ROS content was measured using DCFDA, as previously described for oxidative stress conditions, and the mitochondrial ROS content was measured using 10 μM Mitotracker Red CM-H2 XRos dye mixed with dead E. coli OP50 as a food source.A group of young worms was used as control.To avoid eggs laid during the fertile phase, 15 μg/mL FUDR (Sigma-Aldrich, St. Louis, Missouri) was applied.Furthermore, the animals were moved to new plates with fresh treatment and food twice per week in the case of the aged groups, and once for the young group.Fluorescence intensity was measured using Biosorter (Union Biometrica, Massachusetts).At least 300 worms per group were used.Results were expressed as the percentage of control using the mean of the yellow or red fluorescence intensity for total or mitochondrial ROS content, respectively.
Quantification of Lipofuscin Content.Protocol for young and aged worms was followed as explained in the previous section.Young and old nematodes were treated with 100 μg/mL BRO and the control group was mounted on glass slides with M9 medium and sodium azide.Fluorescence images were captured using an epifluorescence microscope (Eclipse Ni, Nikon, Tokyo, Japan).Images were acquired with a 10× objective lens and the autofluorescence of the worms was analyzed using the software NIS-Elements BR (Nikon, Tokyo, Japan). 22A minimum of 30 worms per group were measured.Results are the percentage to the control for the average of total blue (DAPI) fluorescence intensity for each worm.
Statistical Analysis.The normality of variables was assessed by the Kolmogorov−Smirnov test, and the homogeneity of variance was examined with the Levene test.Non-normally distributed variables were analyzed by using nonparametric tests, while normally distributed variables were subjected to t-student, or one-way ANOVA followed by Bonferroni post hoc tests.The Kruskal−Wallis and Mann−Whitney-U tests were applied for non-normally distributed variables.Data were presented as mean ± standard error of the mean (SEM) from at least 3 independent experiments, unless otherwise specified.Statistical significance was considered at p < 0.05.Survival analysis for lifespan curves was conducted by the Log-rank test.The data visualization and representation were done using the software Microsoft Excel 365 (Washington, USA).All statistical analyses were performed using IBM SPSS 24.0 (Armonk, New York).

■ RESULTS AND DISCUSSION
Characterization of the Broccoli Byproduct Extract.Consumption of broccoli and its compounds has been linked to several benefits for health. 24These effects are often attributed to the abundance of micronutrients and phytochemicals in broccoli.Therefore, the extract from broccoli byproducts investigated in the present study was characterized.Concerning TAC, results were 219 ± 6.30 μM TE/g DE for FRAP, 103 ± 12 μM TE/g DE for DPPH, and 311 ± 9.20 μM TE/g DE for ABTS.Regarding TPC and TFC, it was found 34.4 ± 2.05 mg gallic acid/g DE and 3.87 ± 0.60 mg catechin/ g DE, respectively.TPC, TFC, and TAC in broccoli can vary due to factors like harvest time, cultivar, plant part used, and extraction process, leading to differences in the literature.For instance, TFC of our BRO was found to be lower 25 or within the same range 26 compared with reported values.Similarly, TPC data from our extract was lower, 25 similar, 26 or much higher 27 compared with other studies.TAC measurements with the ABTS test aligned with results obtained from a methanolic extract of broccoli florets. 27The positive chromatogram obtained from the analysis of BRO by HPLC-ESI-QTOF-MS/MS is shown in Figure 2, and the main identified compounds are listed in Table 1.Thirty-four compounds were identified with the main classes being amino acids and derivatives, carbohydrates and derivatives (including the sulfur compounds glucosinolates), carboxylic acids and derivatives (citric acid), and hydroxycinnamic (syringic acid glucuronide) and hydroxybenzoic (chlorogenic acid) acids.Concentrations of identified compounds are listed in Table 1.It should be noted that, given the available information, the precise identification of the compounds as either caffeoylquinic acid or chlorogenic acid cannot be conclusively determined.However, these two compounds are the most plausible candidates based on the data.This is reflected in their repeated listing in Table 1.Among the most abundant compounds, uridine (31.7 ± 0.3 mg/g), dihydroxy-dime-thoxy-benzoxazinone (20 ± 1 mg/g), citric acid/isocitric acid (19 ± 1 mg/g), and methoxy tyrosine (16 ± 1 mg/g) stand out.Quantification of glucosinolates, which are typical compounds present in broccoli, was found to be 0.79 ± 0.02 mg/g.Notably, our extract contained chlorogenic acid, which was also present in other broccoli-related samples in higher concentrations. 26Additionally, one sulfur compound classified as glucosinolate derivate was detected in the sample.Differences in terms of TAC and composition between our extract and those characterized by other authors could be attributed to the fact that our BRO was made from byproducts of broccoli.Toxicity Evaluation In Vivo.Evaluation of the short-term toxic effect of the extract was assessed in the experimental model C. elegans by using the lethality and egg viability tests, which indicated an absence of toxicity in the concentration range 0−10 000 μg/mL (Figure 3A,B, respectively).To further explore the long-term toxicity of BRO within the same dosage range, survival curves were performed (Figure 3C).BRO did not cause a reduction in the lifespan; rather, it led to a significant increase in survival at 100, 500, 1000, and 5000 μg/ mL, as supported by the Long-Rank statistical test which is particularly intriguing for the potential applications in aging.However, 7500 μg/mL reduced the worm survival although there were no significant differences between the control group and the 10 000 μg/mL group.It could be attributed to a hormetic effect of BRO treatment.The theoretical graph depicting the hormesis response is often described as a perfect "U-shape" or "inverted U-shape" in terms of dose−response effects.However, numerous biological models have shown that the hormetic response can manifest as peaks and dips before reaching the maximum hormetic effect, ultimately forming a "U-shape" or "inverted U-shape." 28Notably, previous studies with sulforaphane (a molecule present in broccoli) in this model revealed similar lifespan-extending effects. 29No prior studies have been found evaluating the toxicity of BRO in C. elegans but, in agreement with our findings, Aranaz et al. 30 reported an absence of toxicity for broccoli extract in rats.Therefore, the extract demonstrated practically no toxicity at the doses evaluated in the parameters tested, presenting an engaging prospect for potential biomedical applications.According to these results, nontoxic submaximal concentrations (100, 500, and 1000 μg/mL) were selected for further experiments.

Journal of Agricultural and Food Chemistry
Effect of BRO on Redox Biology-Related Markers.Experiments were conducted to investigate the influence of BRO on cellular redox status, considering its potential impact on aging and AD.The DCFDA probe was used to assess the impact of BRO on intracellular ROS content, and AAPH was employed as an oxidative stress inducer.AAPH led to higher ROS content in live worms compared with the negative control (Figure 4).The three concentrations provided protection to N2 worms against oxidation, showing less ROS content even below that of the negative control group.The most effective one was 100 μg/mL, whereas there were no differences between 500 and 1000 μg/mL.These results agree with authors who found that broccoli and its compounds exerted antioxidant effects in vitro 31−33 and in rodent models. 33,34he effects of BRO on the different transgenic strain GFPreporter of genes related to redox biology at several concentrations (100, 500, and 1000 μg/mL) are collected in Figure 5A.Results indicated that the three dosages led to lower DAF-16 nucleation status, exhibiting a dose-dependent trend as shown by representative images depicted in Figure 5B.However, the expression of the SOD-3 enzyme associated with GFP, as observed in the CF1553 strain (Figure 5D), remained unaffected by any of the BRO treatments.Expression of the SKN-1 transcription factor (Figure 5C) and the GST-4 (Figure 5F) throughout the entire worm was only altered by the highest concentrations (i.e., 500 and 1000 μg/mL), resulting in higher levels.Furthermore, the three concentrations showed higher expression of several HSPs genes, as manifested by the strains TJ375 (Figure 5E) and OS3062 (Figure 5G) in the anterior pharyngeal bulb, exerting a dose-dependent effect in the case of HSP-16.2.The dose-dependent prevention in DAF-16/FOXO nucleation, a pivotal transcription factor in the insulin/insulin-like growth factor 1 signaling (IIS) pathway, is relevant.This finding could be explained by the activation of SKN-1/Nrf2 since this transcription factor can act as a negative regulator of DAF-16/FOXO. 35Interestingly, the expression of SOD-3, a downstream gene of DAF-16/FOXO, remained unaffected, potentially upheld by the higher expression of SKN-1/Nrf2 mediated by BRO treatment.Consistent with this observation, previous studies have shown an upregulation of Nrf2 expression in cells treated with sulforaphane 31 or broccoli juice 32 as well as in rats treated with sulforaphane-enriched broccoli sprouts. 36Furthermore, SKN-1/Nrf2 could be mediating the higher expression of GST-4 and HSPs, which are also its downstream genes.In line with our results, some researchers have proved that overexpression of HSPs is involved in the mild-stress response in C. elegans. 37,38HSPs are generally recognized as important pieces of adaptive responses and their expression is often correlated with the presence of several stressors.However, it is common for some bioactive compounds to present hormetic effects.In our case, BRO treatment may be triggering low/mild stress that results in the activation of multiple stress-responsive genes for the organism's benefit.The low/mild stress induced by BRO may be initiating an adaptive cellular response that prepares worms for subsequent severe stress, conferring thus stress resistance and providing beneficial effects.
In agreement, sulforaphane treatment increased the levels of HSP70 in a transgenic mouse model of AD, which was observed to be related to clear the accumulation of Aβ and tau using primary cell culture. 39Regarding the enzyme GST-4, experimental evidence has shown that GSTs also participate in glucosinolate catabolism, 40 so that may be another reason to explain the observed higher expression level.Therefore, BRO appears to act as an antioxidant agent and a modulator of the redox biology in worms mainly through the activation of the SKN-1/Nrf2 transcription factor.These findings hold significant promise for potential applications of BRO treatments in physiological conditions involving alterations in redox biology, such as aging, or in diseases like AD.
Effect of BRO on Alzheimer's Disease Markers.In vitro AChE inhibitory capacity as well as in vivo effects on Aβrelated toxicity and influence on Tau-associated proteotoxicity   were evaluated as AD markers.Concerning AChE, IC 50 for BRO was 2869 μg/mL, calculated from a dose−response curve and using the equation "y = −2 × 10 −06 x 2 + 0.026x − 8.1345."IC 50 for PHY was 0.009 μg/mL, calculated from the equation "y = −223565 x 2 + 8817.3x− 10.817".Alterations in the cholinergic system are associated with AD pathology.AChE and BChE play a role in degrading the neurotransmitter Ach, and their increased activity appears to promote Aβ fibril formation.The levels of cholinesterases are increased in the brain of AD patients, resulting in a deficit in cerebral cholinergic neurotransmitters ultimately leading to memory loss and other cognitive symptoms. 41Thus, compounds able to inhibit them could be an interesting approach for the treatment of the symptomatology of this disease.Scientific literature on the effects of florets or stems of broccoli in this context is limited, but other parts of the vegetable such as the leaves have been evaluated in this regard.Data from in vitro experiments revealed the AChE inhibitory activity of the chloroform fraction of broccoli leaves extract 33 and of different isothiocyanate compounds. 42In vivo studies have also confirmed this effect. 33,34,36Nevertheless, the IC 50 of byproduct was much higher than that of the positive control PHY.PHY is a potent parasympathomimetic alkaloid known to inactivate ChE and increase Ach levels at cholinergic synapses in the nervous systems. 43Therefore, the AChE inhibitory activity exhibited by BRO treatment should be considered relatively modest when compared with drugs specifically designed for that purpose.
The amyloid cascade hypothesis, a widely accepted theory in AD, posits that Aβ deposition initiates a sequence of events, including microglial activation, inflammatory response, and reactive astrocytosis, ultimately leading to neuronal dysfunction. 44Thus, the influence of BRO on the Aβ toxicity was elucidated by the paralysis test, which was carried out using the transgenic strain CL4176.These worms express the human Aβ 1−42 peptide in muscle cells, leading to a paralysis phenotype when the incubation temperature is raised from 16 to 25 °C.The assessed concentrations of BRO (100, 500, and 1000 μg/ mL) demonstrated a clear delay in paralysis in treated worms (Figure 6A).Significant differences between the control and treated groups were observed from 22 h after the temperature increase until the last reading, with no differences between dosages.At the end reading point, over 40% of the treated worms remained unparalyzed, compared with 20% in the control group.These results were corroborated by thioflavin T staining, which specifically binds to Aβ aggregates.The positive control displayed a large amount of Aβ deposits as evidenced by the presence of numerous green shiny dots (Figure 6C).In contrast, the negative control showed a total absence of such aggregates, and the BRO treatments manifested a significantly lower amount compared with the positive control.There are no data on the effect of broccoli or its byproducts on Aβ aggregation, although positive results have been demonstrated for sulforaphane in transgenic mice. 45cumulation of hyperphosphorylated tau protein is another hallmark of AD, and studies have indicated that Aβ and tau act synergistically to promote the pathological progression of the disease and neuronal loss. 44Therefore, reducing the accumulation of both proteins has been considered one of the most promising therapeutic approaches for AD. C. elegans transgenic strain BR5706 exhibits accelerated aggregation of insoluble Tau in neurons, leading to defects in the nervous system and altered movements.WormLab station and associated software were used to investigate swimming locomotive behavior.Swimming speed measured the velocity of the animals during a two-stroke interval, while activity quantified the brush stroke normalized by the time taken to perform the two strokes.Treatment for 72 h with 100 and 1000 μg/mL BRO led to higher swimming speed and activity than control (Figure 6D,E).The concentration of 500 μg/mL was less effective than the other two but still demonstrated a significant difference compared with the control group, particularly for the swimming speed parameter.These findings indicate the potential of BRO to ameliorate the effects of tau protein aggregation in this C. elegans model.Scientific literature about the effect of broccoli or its compounds on tau protein is quite scarce, but again, sulforaphane cleared the accumulation of tau in a primary cell culture 39 and the hyperphosphorylation in a transgenic mice model. 45Other natural products have also demonstrated a positive effect on Aβ and Tau toxicity in this experimental model, such as strawberry, 14,22 avocado honey, 23 and oleuropein- 16 and hydroxytyrosol-17 rich olive leaves extract.
Most of the studies investigating mechanisms underlying the effect of natural compounds against Aβ-induced paralysis or tau-induced movement impairment in C. elegans focus on the pathways addressed in previous sections: those related to oxidative stress, heat shock response, insulin signaling cascade, and redox homeostasis. 46According to that, RNAi for those pathways or proteins was applied to the paralysis and movement analysis, with the lowest effective concentration of BRO (100 μg/mL) selected for the tests.RNAi was administered to the worms by feeding through the E. coli HT115 that contained dsRNA for skn-1, daf-16, hsp-16.2,and sod-3 genes.Figure 6B shows RNAi paralysis assay of CL4176 worms for BRO 32 h after incubation temperature rising.The inhibition of sod-3 and hsp-16.2genes led to a significantly lower percentage of nonparalyzed worms.However, the paralysis was not modified by the administration of RNAi for skn-1 or daf-16, indicating that these genes were not directly associated to the observed benefits.On the other hand, the inhibition of skn-1 and hsp-16.2led to a lower swimming speed in BR5706 worms leading to nonsignificant differences when compared with the nontreated group.However, only hsp-16.2 was involved in the BRO-induced higher activity index (Figure 6F,G).These findings provide valuable insights into the specific genes that might mediate the beneficial effects of BRO in attenuating Aβ toxicity and Tau proteotoxicity in C. elegans.
The key protein common to the positive effects of BRO on Aβ Figure 6.continued temperature upshift (40× magnification) for negative and positive controls, and treated worms with BRO 100, 500, and 1000 μg/mL.White arrow shows the Aβ aggregated.(D, E) Effects of BRO 100, 500, and 1000 μg/mL on locomotive parameters in the transgenic strain BR5706: Swimming speed (D) and activity index (E).(F, G) Influence of the different RNAi on swimming speed (F) and activity index (G) for BRO 100 μg/mL.Results are expressed as mean ± SEM.Statistically significant differences between groups (p < 0.05) are represented with different lowercase letters.Significant differences (p < 0.05) between the treatment with and without the RNAi are represented by *.
and Tau toxicity was HSP-16.2.HSP-16.2 plays a crucial role in maintaining protein homeostasis involved in highly conserved stress responses that prevent protein mismanagement.In C. elegans, HSP-16.2directly interacts with Aβ peptide, disrupting its oligomerization and reducing the formation of toxic species. 47,48Furthermore, SOD-3 was related to the protective effect against Aβ toxicity, while the SKN-1 factor was associated with the effect on tau toxicity.RNAi results agree in part with experiments on redox biologyrelated transgenic strains such as the participation of HSP-16.2.However, the SKN-1/Nrf2 was not modified by 100 μg/mL in baseline situations (GFP-reporter strains) but it was involved in the AD benefits, same as observed for SOD-3, which might indicate that those proteins are activated under AD.It is conceivable that, in strains under normal conditions, certain proteins or pathways remain deactivated because they are unnecessary in that context, hence BRO does not exert any effect.However, the presence of Aβ or tau proteins may induce stress, demanding the activation of those specific pathways, creating an environment where BRO can effectively modulate the stress with increased activity compared with normal conditions.This scenario aligns with other findings reported in another study in C. elegans using oleuropein-rich olive leaves extract. 16ffect of BRO on Oxidative Stress Markers in Aging.Considering the social and health importance of aging and since AD is an age-related disease, in the present study, the effect of BRO was preliminary assessed concerning this physiological situation.One of the features of aging is the increase in ROS production with subsequent oxidative damage. 49To test this hypothesis, two different populations of N2 worms were used: 5-day-old animals as the young control group, and 12-day-old animals as both, control and treated old nematodes.The age and synchronization of the worms were adjusted to ensure the same reading point for both populations.DCFDA and Mitotracker probes were used to test the effect of BRO on intracellular and mitochondrial ROS content, respectively.Aging led to significantly higher values for intracellular (Figure 7A,7B) and mitochondrial (Figure 7C,7D) ROS, standing out the total content since it was three times higher in the old control group than in the young counterparts.BRO at 100 μg/mL exhibited substantial protection against the age-related rise in ROS levels in both probes.Specifying, BRO treatment led to a less total and mitochondrial content by approximately 20 and 11%, respectively, when compared with the aged control group.These results demonstrated the ROS theory of aging under the present model showing the antiaging potential of our broccoli byproduct.Lipofuscin, an indicator of both oxidative stress and aging in C. elegans, is a native autofluorescent pigment formed by cross-linked polymeric substances due to oxidative processes that accumulate progressively over time, particularly in lysosomes and gut granules within the intestine.Its measurement is used as a marker for evaluating healthspan in aging, being one of the widely studied age-dependent biomarkers in nematodes. 50Results on lipofuscin are presented in Figure 7E,F.Aging led to a higher lipofuscin content, with values of control aged worms being more than three times higher than their young counterparts.In this parameter, BRO did not exhibit any significant effect.That observation could be attributed to the inherent nature and implications of the lipofuscin pigment.The formation and accumulation of lipofuscin lead to a variety of defects in cellular function and homeostasis.It is associated with progressive decline in lysosomal function and disruptions in both phagocytosis and autophagy processes, which subsequently affect numerous cellular activities.Lipofuscin acts as proteasome inhibitor by directly binding on proteasome complexes.Consequently, processes unrelated to ROS are also linked to lipofuscin accumulation, including autophagy. 51,52Therefore, that kind of process may be altered in aged worms, which may not be modulated by BRO, explaining the noneffect observed in lipofuscin content.No data on broccoli or its byproducts have been found; however, other treatments, such as strawberry extract, partially prevented the accumulation of this pigment at the same concentration as BRO, probably mediated by anthocyanins. 22hile this research provides valuable insights, the specific molecules responsible for the observed effects remain unclear.However, drawing from literature, some of the primary compounds found in the extract, such as uridine, hydroxycinnamic acids, or the characteristic glucosinolate, could account for these positive effects.For instance, studies have demonstrated that glucosinolate-rich broccoli sprouts protected against oxidative stress in humans, 53 and its derivate isothiocyanates interfered with the molecular cascades of AD pathogenesis, preventing functional loss in neurons. 54urthermore, chlorogenic acid reduced the aging-induced ROS production in C. elegans and increased worms' lifespan and healthspan. 55Caffeoylquinic acid reversed cognitive deficits in AD model mice, 56 and both phenolic acids exhibited neuroprotective properties by inhibiting AChE and BChE activities as well as preventing oxidative stress-induced neurodegeneration in rats. 57Additionally, lower uridine levels have been associated with AD progression, 58 and the administration of a uridine prodrug reduced cognition impairments, tau phosphorylation, lipid peroxidation, ROS levels, and mitochondrial DNA damage. 59n conclusion, the extract assayed in the present study, derived from broccoli byproducts, exhibited significant antioxidant activity attributed to its profile and content on bioactive compounds, demonstrated both in vitro and in the C. elegans model.In vivo, this effect could be mediated by the modulation of several markers associated with redox biology, highlighting the activation of the transcription factor skn-1/ Nrf 2 and its downstream genes gst-4 and hsps.Regarding AD features, the extract demonstrated to possess a moderated AChE inhibitory capacity in vitro and the ability to prevent in vivo the Aβ-and tau-induced proteotoxicity in transgenic strains via SOD-3 and SKN-1, respectively, and HSP-16.2 for both parameters.Results from the RNAi tests mostly agreed with those observed in GFP-reporter transgenic strains, with all of the benefits being independent of DAF-16/FOXO pathway.Furthermore, a preliminary study on aging indicated that the extract effectively prevented intracellular and mitochondrial ROS accumulation in aged worms and extending at the same time their lifespan.These findings pave the way for further exploration of underlying mechanisms in the aging context.Therefore, this broccoli byproduct extract displayed the ability to modulate redox biology, influencing positively then on aging and AD.Altogether, results hold significant importance as they demonstrate the remarkable efficacy of the broccoli byproduct extract.It is noteworthy that the extract is derived from a broccoli byproduct rather than directly from the broccoli itself and it supports the use of broccoli byproducts for nutraceutical or functional food development.Doing this would not only manage vegetable processing waste but also enhance the productivity and sustainability of the broccoli crop while providing significant health benefits.

Figure 1 .
Figure 1.Experimental design for in vivo aging experiments.

Figure 3 .
Figure 3. Acute-and long-term toxicity tests in C. elegans.(A) Lethality test in the N2 strain.(B) Egg viability test in the N2 strain.Results are expressed as mean ± SEM. (C) Long-term toxicity evaluation through the Kaplan−Meier survival curves for different concentrations of BRO (100, 500, 1000, 5000, 7500, and 10 000 μg/mL).Statistically significant differences were considered when p < 0.05.For survival curves, the Long-Rank test was used.CTL = control group.

Figure 7 .
Figure 7. Effect of broccoli byproduct extract (BRO) 100 μg/mL on oxidative stress markers on aging (young worms = 5 days old; old worms = 12 days old).(A) Intracellular reactive oxygen species (ROS) content measured by the DCFDA technique.(B) Representative dot plots panels of intracellular ROS content vs TOF (time-of-flight; worm size) of yellow fluorescence intensity extracted from flow cytometer software.(C) Mitochondrial ROS content measured by Mitotracker staining.(D) Representative dot plots panels of mitochondrial ROS content vs TOF of red fluorescence intensity extracted from flow cytometer software.(E) Lipofuscin content.(F) Representative images of lipofuscin for each group (10× magnification) obtained by using an epi-fluorescence microscope with a DAPI (blue) filter.Lowercase letters, when different, represent statistically significant differences (p < 0.05).Results are expressed as mean ± SEM.CTL = control group.

Table 1 .
1dentification and Quantification of Individual Compounds Present in Broccoli Byproduct Extract (BRO)1 1Quantification data are expressed as mg of compound/g dry extract.SD = standard deviation.Ref 11,12.